Drug
P-Aminohippuric Acid clinical trials
Also written Para-aminohippurate.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 4
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
University of Colorado, Denver (4) · Brigham and Women's Hospital (1) · Vanderbilt University Medical Center (1) · Yale University (1)
Often tested with
Tested in the same studies.
Sacubitril valsartan sodium hydrate (2) · Sacubitril valsartan (2) · Canagliflozin (1) · Angiotensin II (1) · Norepinephrine (1) · Icatibant (1) · Aprepitant (1)
Studies
Open first, then newest update. How each study uses p-Aminohippuric Acid is read from its arms, and is right about nine times in ten.
Testing it · 7
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2CompletedPhase 4Vanderbilt University Medical CenterNCT04113109Written as Para-aminohippurate
- Renal Mechanism of SGLT2 InhibitionActive, not recruitingPhase 2University of Colorado, DenverNCT05507892Written as Aminohippurate Sodium Inj 20%
- Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3CompletedPhase 4Yale UniversityNCT04649229Written as Para-aminohippurate
- Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 DiabetesCompletedPhase 1/2University of Colorado, DenverNCT03620773Written as Aminohippurate Sodium Inj 20%
- Caveolin-1 and Vascular DysfunctionActive, not recruitingPhase 1Brigham and Women's HospitalNCT01426529Written as Para-aminohippuric Acid
- Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyActive, not recruitingPhase 1/2University of Colorado, DenverNCT03584217Written as Aminohippurate Sodium Inj 20%
- Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic FunctionCompletedPhase 1/2University of Colorado, DenverNCT03618420Written as Aminohippurate Sodium Inj 20%
Given in every arm · 3 — p-Aminohippuric Acid is usual care beside what is tested
- MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 DiabetesRecruitingPhase 1Kalie TommerdahlNCT05065372Written as Aminohippurate Sodium 20 % Injection
- Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male VolunteersWithdrawnPhase 4Universitätsklinikum Hamburg-EppendorfNCT01156220Written as aminohippurate sodium
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedPhase 1ViiV HealthcareNCT01214993Written as Para-aminohippurate infusion
Codes
What other systems call p-Aminohippuric Acid · ClinicalTrials.gg INT007948
- MeSH (NLM) D010130p-Aminohippuric AcidConfirmed NLM, Wikidata
- UNII (FDA) Y79XT83BJ9AMINOHIPPURIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 7832Confirmed FDA, Wikidata
- Wikidata Q291271aminohippuric acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76046Aminohippuric AcidOne source FDA
- DrugBank DB00345One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010130 | p-Aminohippuric Acid | Confirmed NLM, Wikidata |
| UNII (FDA) | Y79XT83BJ9 | AMINOHIPPURIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7832 | — | Confirmed FDA, Wikidata |
| Wikidata | Q291271 | aminohippuric acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76046 | Aminohippuric Acid | One source FDA |
| DrugBank | DB00345 | — | One source Wikidata |
Also registered as aminohippurate sodium (UNII SUO3KVS1O9 · RxNorm 203194).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.